Gossamer Bio Inc (NASDAQ: GOSS) on Monday, plunged -5.21% from the previous trading day, before settling in for the closing price of $0.78. Within the past 52 weeks, GOSS’s price has moved between $0.45 and $1.88.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 35.82%. With a float of $188.87 million, this company’s outstanding shares have now reached $225.41 million.
Let’s look at the performance matrix of the company that is accounted for 135 employees.
Gossamer Bio Inc (GOSS) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Gossamer Bio Inc is 16.27%, while institutional ownership is 79.45%. The most recent insider transaction that took place on Mar 27 ’24, was worth 26,773. In this transaction President & CEO of this company sold 23,172 shares at a rate of $1.16, taking the stock ownership to the 120,293 shares. Before that another transaction happened on Mar 27 ’24, when Company’s COO/CFO sold 6,430 for $1.16, making the entire transaction worth $7,431. This insider now owns 92,737 shares in total.
Gossamer Bio Inc (GOSS) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 35.82% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.20% during the next five years compared to 11.99% growth over the previous five years of trading.
Gossamer Bio Inc (NASDAQ: GOSS) Trading Performance Indicators
Gossamer Bio Inc (GOSS) is currently performing well based on its current performance indicators. A quick ratio of 5.94 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.38, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.70 in one year’s time.
Technical Analysis of Gossamer Bio Inc (GOSS)
Gossamer Bio Inc (NASDAQ: GOSS) saw its 5-day average volume 0.89 million, a negative change from its year-to-date volume of 1.19 million. As of the previous 9 days, the stock’s Stochastic %D was 6.23%. Additionally, its Average True Range was 0.09.
During the past 100 days, Gossamer Bio Inc’s (GOSS) raw stochastic average was set at 6.88%, which indicates a significant increase from 6.23% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 44.94% in the past 14 days, which was lower than the 85.29% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.1732, while its 200-day Moving Average is $0.9890. Nevertheless, the first resistance level for the watch stands at $0.8102 in the near term. At $0.8773, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.9248. If the price goes on to break the first support level at $0.6956, it is likely to go to the next support level at $0.6481. Assuming the price breaks the second support level, the third support level stands at $0.5810.
Gossamer Bio Inc (NASDAQ: GOSS) Key Stats
Market capitalization of the company is 167.61 million based on 225,582K outstanding shares. Right now, sales total 0 K and income totals -179,820 K. The company made 0 K in profit during its latest quarter, and -48,150 K in sales during its previous quarter.
